Psyence Biomedical Ltd Stock Buy Hold or Sell Recommendation
| PBM Stock | USD 3.46 0.05 1.42% |
Considering the 90-day investment horizon and your below-average risk tolerance, our recommendation regarding Psyence Biomedical Ltd is 'Cautious Hold'. The recommendation algorithm takes into account all of Psyence Biomedical's available fundamental, technical, and predictive indicators you will find on this site.
Check out Psyence Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Psyence and provide practical buy, sell, or hold advice based on investors' constraints. Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Psyence |
Execute Psyence Biomedical Buy or Sell Advice
The Psyence recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Psyence Biomedical Ltd. Macroaxis does not own or have any residual interests in Psyence Biomedical Ltd or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Psyence Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Psyence Biomedical Trading Alerts and Improvement Suggestions
| Psyence Biomedical generated a negative expected return over the last 90 days | |
| Psyence Biomedical has high historical volatility and very poor performance | |
| Psyence Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0. | |
| Psyence Biomedical Ltd has about 281.63 K in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Psyence Biomedical has a frail financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from businesswire.com: VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis |
Psyence Biomedical Returns Distribution Density
The distribution of Psyence Biomedical's historical returns is an attempt to chart the uncertainty of Psyence Biomedical's future price movements. The chart of the probability distribution of Psyence Biomedical daily returns describes the distribution of returns around its average expected value. We use Psyence Biomedical Ltd price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Psyence Biomedical returns is essential to provide solid investment advice for Psyence Biomedical.
| Mean Return | -2.9 | Value At Risk | -18.55 | Potential Upside | 9.25 | Standard Deviation | 9.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Psyence Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Psyence Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Psyence Biomedical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Psyence Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Psyence stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -2.9 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 9.31 | |
Ir | Information ratio | -0.33 |
Psyence Biomedical Volatility Alert
Psyence Biomedical Ltd is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Psyence Biomedical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Psyence Biomedical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Psyence Biomedical Fundamentals Vs Peers
Comparing Psyence Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Psyence Biomedical's direct or indirect competition across all of the common fundamentals between Psyence Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Psyence Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Psyence Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Psyence Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Psyence Biomedical to competition |
| Fundamentals | Psyence Biomedical | Peer Average |
| Return On Asset | -1.26 | -0.14 |
| Current Valuation | 12.32 M | 16.62 B |
| Shares Outstanding | 16.7 M | 571.82 M |
| Shares Owned By Insiders | 58.48 % | 10.09 % |
| Shares Owned By Institutions | 13.24 % | 39.21 % |
| Number Of Shares Shorted | 823.87 K | 4.71 M |
| EBITDA | (2.75 M) | 3.9 B |
| Net Income | (51.16 M) | 570.98 M |
| Cash And Equivalents | 281.63 K | 2.7 B |
| Cash Per Share | 0.02 X | 5.01 X |
| Total Debt | 10.45 M | 5.32 B |
| Current Ratio | 7.95 X | 2.16 X |
| Book Value Per Share | (0.82) X | 1.93 K |
| Cash Flow From Operations | (2.95 M) | 971.22 M |
| Short Ratio | 0.71 X | 4.00 X |
| Earnings Per Share | (7.82) X | 3.12 X |
| Beta | -0.36 | -0.15 |
| Market Capitalization | 2.6 M | 19.03 B |
| Total Asset | 1.13 M | 29.47 B |
| Retained Earnings | (57.46 M) | 9.33 B |
| Working Capital | (10.98 M) | 1.48 B |
| Current Asset | 327 K | 9.34 B |
| Current Liabilities | 42 K | 7.9 B |
| Net Asset | 1.13 M |
Psyence Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Psyence . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Psyence Biomedical Buy or Sell Advice
When is the right time to buy or sell Psyence Biomedical Ltd? Buying financial instruments such as Psyence Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Psyence Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Currency ETFs Thematic Idea Now
Alternative Currency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Alternative Currency ETFs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Currency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Psyence Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.